Literature DB >> 22833084

Squamous cell carcinoma and pleomorphic sarcoma (MFH) arising in a mature cystic teratoma of the ovary.

Eleonora Savitchi1, Sumati Rao.   

Abstract

Malignant transformation of a mature ovarian teratoma is a rare occurrence predominantly in the postmenopausal period. All histologic types can be seen; however, squamous cell carcinoma accounts for over 75% of cases. Sarcomatous transformation is much more uncommon, with cases of angiosarcoma, rhabdomyosarcoma, leiomyosarcoma and liposarcoma arising in a mature ovarian teratoma described in literature. We report a case of squamous cell carcinoma and pleomorphic sarcoma arising in a mature cystic teratoma of the ovary in a 58-year-old woman. The tumor shows both epithelial and stromal components. The epithelial component is moderately-differentiated squamous cell carcinoma with foci of keratinization. The stromal component is significant for an abundance of giant cells, enlarged bizarre nuclei, and marked mitotic activity. This is a unique report of malignant transformation of a benign ovarian teratoma showing both epithelial and sarcomatous elements.

Entities:  

Mesh:

Year:  2012        PMID: 22833084     DOI: 10.1097/PGP.0b013e318249289e

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  3 in total

1.  A rare case report of squamous-cell carcinoma arising from mature cystic teratoma of ovary.

Authors:  E Kalampokas; I Boutas; E Kairi-Vasilatou; N Salakos; K Panoulis; L Aravantinos; C Damaskos; T Kalampokas; E Deligeoroglou
Journal:  G Chir       Date:  2014 Sep-Oct

2.  Leiomyosarcoma and Squamous Cell Carcinoma Arising in Mature Cystic Teratoma of the Ovary.

Authors:  Tip Pongsuvareeyakul; Kornkanok Sukpan; Somjet Chaicharoen; Surapan Khunamornpong
Journal:  Case Rep Pathol       Date:  2017-07-02

Review 3.  Ovarian mucinous cystic tumor associated with sarcomatous mural nodule and benign Brenner tumor: A case report and literature review.

Authors:  Shaolong Yang; Li Wang; Kai Sun
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.